1.71
price down icon2.29%   -0.04
after-market Handel nachbörslich: 1.71
loading
Schlusskurs vom Vortag:
$1.75
Offen:
$1.7752
24-Stunden-Volumen:
15,001
Relative Volume:
0.41
Marktkapitalisierung:
$23.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-13.59M
KGV:
-1.5833
EPS:
-1.08
Netto-Cashflow:
$-19.79M
1W Leistung:
-11.86%
1M Leistung:
+12.50%
6M Leistung:
-50.43%
1J Leistung:
-68.22%
1-Tages-Spanne:
Value
$1.6598
$1.7752
1-Wochen-Bereich:
Value
$1.6598
$2.04
52-Wochen-Spanne:
Value
$1.43
$6.0199

Calcimedica Inc Stock (CALC) Company Profile

Name
Firmenname
Calcimedica Inc
Name
Telefon
858-952-5500
Name
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Name
Mitarbeiter
15
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
CALC's Discussions on Twitter

Vergleichen Sie CALC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CALC
Calcimedica Inc
1.71 27.11M 0 -13.59M -19.79M -1.08
Biotechnology icon
ONC
Beigene Ltd Adr
238.76 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
434.03 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.2548 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
596.85 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
72.69 5.92B 0 -153.72M -103.81M -2.00

Calcimedica Inc Aktie (CALC) Neueste Nachrichten

pulisher
May 17, 2025

HC Wainwright Reiterates “Buy” Rating for CalciMedica (NASDAQ:CALC) - Defense World

May 17, 2025
pulisher
May 15, 2025

CalciMedica (CALC) Receives Reiteration of Buy Rating with $16 P - GuruFocus

May 15, 2025
pulisher
May 14, 2025

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune

May 14, 2025
pulisher
May 10, 2025

CalciMedica (CALC) Expected to Announce Quarterly Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

CalciMedica Inc expected to post a loss of 31 cents a shareEarnings Preview - TradingView

May 09, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Purchases New Stake in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

May 07, 2025
pulisher
May 04, 2025

Geode Capital Management LLC Boosts Stock Holdings in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

May 04, 2025
pulisher
Apr 28, 2025

Bristol-Myers Squibb (NYSE:BMY) vs. CalciMedica (NASDAQ:CALC) Critical Review - Defense World

Apr 28, 2025
pulisher
Apr 24, 2025

CalciMedica (NASDAQ:CALC) Shares Up 0.7% – Here’s Why - Defense World

Apr 24, 2025
pulisher
Apr 17, 2025

CalciMedica's Breakthrough Research Takes Center Stage at Two Elite Medical Conferences - Stock Titan

Apr 17, 2025
pulisher
Apr 17, 2025

CalciMedica Announces Presentations at Upcoming Medical Meetings - PR Newswire

Apr 17, 2025
pulisher
Apr 03, 2025

Analysts Offer Predictions for CalciMedica Q4 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 02, 2025

CalciMedica Inc. (CALC) Moves to Buy: Rationale Behind the Upgrade - Yahoo Finance

Apr 02, 2025
pulisher
Apr 02, 2025

Corient Private Wealth LLC Buys New Shares in CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

CalciMedica (NASDAQ:CALC) Receives “Buy” Rating from HC Wainwright - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Corient Private Wealth LLC Acquires Shares of 38,000 CalciMedica, Inc. (NASDAQ:CALC) - The AM Reporter

Apr 02, 2025
pulisher
Apr 01, 2025

Graybug Vision stock hits 52-week low at $1.81 - Investing.com India

Apr 01, 2025
pulisher
Apr 01, 2025

Graybug Vision stock hits 52-week low at $1.81 By Investing.com - Investing.com South Africa

Apr 01, 2025
pulisher
Apr 01, 2025

H.C. Wainwright maintains $16 target on CalciMedica stock - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

CalciMedica’s Strong Financial Position and Promising Clinical Pipeline Justify Buy Rating - TipRanks

Apr 01, 2025
pulisher
Apr 01, 2025

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference - PR Newswire

Apr 01, 2025
pulisher
Mar 27, 2025

CalciMedica says cash sufficient to fund operating plan into mid-2026 - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

CALCIMEDICA Earnings Results: $CALC Reports Quarterly Earnings - Nasdaq

Mar 27, 2025
pulisher
Mar 27, 2025

CalciMedica Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates - Citizen Tribune

Mar 27, 2025
pulisher
Mar 27, 2025

Calcimedica Reports 2024 Financial Results And Provides Clinical & Corporate Updates - MarketScreener

Mar 27, 2025
pulisher
Mar 25, 2025

CalciMedica (CALC) to Release Earnings on Thursday - The AM Reporter

Mar 25, 2025
pulisher
Mar 24, 2025

CalciMedica Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 24, 2025
pulisher
Mar 20, 2025

Atria Investments Inc Buys 7,509 Shares of CalciMedica, Inc. (NASDAQ:CALC) - Defense World

Mar 20, 2025
pulisher
Mar 20, 2025

CalciMedica (CALC) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 20, 2025
pulisher
Mar 13, 2025

Graybug Vision stock hits 52-week low at $1.83 amid challenges - Investing.com

Mar 13, 2025
pulisher
Mar 11, 2025

Rani Therapeutics (NASDAQ:RANI) versus CalciMedica (NASDAQ:CALC) Financial Contrast - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Promising Phase 2 Results and Market Potential Drive Buy Rating for CalciMedica’s Auxora - TipRanks

Mar 07, 2025
pulisher
Mar 06, 2025

Short Interest in CalciMedica, Inc. (NASDAQ:CALC) Increases By 35.0% - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Latham & Watkins Advises CalciMedica in Secured Growth Financing - Latham & Watkins LLP

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures $32.5 million credit facility By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures credit facility for up to $32.5M - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica Secures Credit Facility For Up To $32.5 Million -March 05, 2025 at 07:44 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica secures $32.5 million credit facility - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica Secures Credit Facility for Up to $32.5 Million - Finansavisen

Mar 05, 2025
pulisher
Mar 05, 2025

CalciMedica (NASDAQ:CALC) Given “Buy” Rating at HC Wainwright - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

Graybug Vision stock hits 52-week low at $1.95 amid challenges - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica reports reduced mortality in AKI trial with Auxora - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica Highlights Auxora’s Potential in COVID-19 Treatment - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica reports reduced mortality in AKI trial with Auxora By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica’s Auxora shows mortality reduction in COVID-19 pneumonia trial - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora™ in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference - PR Newswire

Mar 04, 2025
pulisher
Mar 04, 2025

CalciMedica, Inc. (CALC): Among Penny Stocks with Insider Buying in 2025 - Insider Monkey

Mar 04, 2025
pulisher
Mar 03, 2025

12 Penny Stocks with Insider Buying in 2025 - Insider Monkey

Mar 03, 2025
pulisher
Feb 19, 2025

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference - PR Newswire

Feb 19, 2025
pulisher
Feb 03, 2025

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Longview News-Journal

Feb 03, 2025

Finanzdaten der Calcimedica Inc-Aktie (CALC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$581.44
price down icon 0.60%
$1.39
price up icon 6.92%
$32.50
price down icon 0.28%
$289.00
price down icon 1.22%
$4.2299
price up icon 5.48%
$72.69
price down icon 1.89%
Kapitalisierung:     |  Volumen (24h):